Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.
Behav Med. 2010 Oct-Dec;36(4):130-40. doi: 10.1080/08964289.2010.525263.
The survival advantages associated with different treatments for localized prostate cancer (PCa) continue to be uncertain. We evaluated patients' use of an interactive CD-ROM-based decision aid designed to improve informed decision making about PCa treatment. Newly diagnosed, early-stage PCa patients who had not made a treatment decision completed a baseline telephone interview (N = 132), were mailed the CD-ROM, and completed a one-month follow-up interview (N = 120; 91%). Compared to non-users (21%), CD-users (79%) preferred to make an independent rather than a shared treatment decision (OR = 3.5, CI 1.2,10.5). The majority of users (63%-90%) responded positively regarding the length and clarity of the information. Further, 76% reported using the CD as much/more than other information sources. A preference for having less decisional control predicted greater satisfaction with the CD (F[7,87] = 4.75, p < .05). Electronic utilization data revealed that the topics most accessed concerned treatment information and that users spent over an hour using the CD (median = 72 minutes). This electronic educational tool was well-accepted by patients and may be particularly useful for patients who desire less control over their treatment decisions and who are less proactive in seeking information on their own.
局部前列腺癌（PCa）不同治疗方法相关的生存优势仍不确定。我们评估了患者使用基于交互式 CD-ROM 的决策辅助工具的情况，该工具旨在改善 PCa 治疗决策的知情程度。未做出治疗决策的新诊断早期 PCa 患者完成了基线电话访谈（N=132），并邮寄了 CD-ROM，随后完成了一个月的随访访谈（N=120；91%）。与非使用者（21%）相比，CD 使用者（79%）更倾向于做出独立而非共同的治疗决策（OR=3.5，CI 1.2,10.5）。大多数使用者（63%-90%）对信息的长度和清晰度表示肯定。此外，76%的人报告说，他们使用 CD 的频率与其他信息来源一样高/更高。对决策控制的较少需求预测对 CD 的满意度更高（F[7,87] = 4.75，p <.05）。电子使用数据显示，最受关注的主题是治疗信息，用户使用 CD 的时间超过一小时（中位数=72 分钟）。这种电子教育工具深受患者欢迎，对于那些希望对治疗决策的控制较少，并且不太主动自行寻找信息的患者可能特别有用。
